Brenntag North America, Inc. – Trademark Portfolio
Entity Type: 03
Brenntag North America, Inc. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 5 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include AQUAPURE and ULTRAPURE DEF DELIVERED NATIONWIDE. The owner is based in Reading, PA.
5083 Pottsville Pike
Reading, PA 19605
Showing of trademarks Trademarks
Trademark Classifications
Brenntag North America, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Brenntag North America, Inc. have?
Brenntag North America, Inc. has 8 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 5 cancelled.
What trademark classes does Brenntag North America, Inc. file in?
Brenntag North America, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 35 (Advertising & Business), Class 2 (Paints). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Brenntag North America, Inc.'s most well-known trademarks?
Brenntag North America, Inc.'s registered trademark portfolio includes well-known marks such as AQUAPURE and ULTRAPURE DEF DELIVERED NATIONWIDE. These are among 2 currently registered trademarks in the portfolio.
What is Brenntag North America, Inc.'s trademark registration success rate?
Brenntag North America, Inc. has a 25% trademark registration rate, with 2 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.